MHMonir Hossain

Monir Hossain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Monir Hossain has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ex Vivo Hydrodynamic Assessment of Expanded Polytetrafluoroethylene Trileaflet Pulmonary Valves

    by Muhammad Aanish Raees, Spencer Hogue, Alan O’DOnnell, James F. Cnota, David L. S. Morales, David G. Lehenbauer, Farhan Zafar, James A. Quintessenza, James S. Tweddell, Awais Ashfaq

    Handmade trileaflet valves using expanded polytetrafluorethylene (ePTFE) have been considered a viable option for pulmonary valve replacement. Studies have performed ex vivo testing of adult sized valves, data on pediatric-sized ePTFE valves is limited. Our aim was to evaluate pediatric-sized ePTFE valves and ovine tissue valves as comparison to assess performance. Trileaflet valves were constructed using 0.1 mm ePTFE Gore-Tex membrane ranging from 14 to 20 mm in size and sutured into Hemashield conduits. Ovine pulmonary valves were harvested and ranged from 14 to 20 mm. Valves were tested under pediatric pulmonary conditions using a hydrodynamic tester. Regurgitation fraction (RF%), closing volume (CV%), closing volume duration (CVd, second), effective orifice area (EOA, cm 2 ), and peak pressure (PMax, mm Hg), and mean pressure (PMean, mm Hg) were measured. All valves reached goal cardiac output with mild regurgitation. Ovine pulmonary valves had significantly lower RF% than ePTFE valves (14 mm: 4.1 vs . 9.4%; 16 mm: 5.6 vs. 13.8%; 18 mm: 3.5 vs. 9.8%; 20 mm: 5.4% vs. 14.4%; p < 0.05, Table 3). Peak pressure was not significantly different between ovine versus ePTFE groups (14 mm: 37 vs. 24 mm Hg; 16 mm: 27 vs. 27 mm Hg; 18 mm: 26 vs. 27 mm Hg; 20 mm: 13 vs. 12 mm Hg). Expanded polytetrafluorethylene valves offer a viable option for pulmonary valve replacement given mild RF%, and comparable PMax. Further work is needed to understand the interplay between leaflet design and function.

  • A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation

    by Hosam F. Ahmed, Kevin Kulshrestha, Spencer Hogue, Monir Hossain, Yin Zhang, Wida S. Cherikh, Awais Ashfaq, David L. S. Morales, Don Hayes

    Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.


  • Donation after circulatory death significantly reduces waitlist times while not changing post–heart transplant outcomes: A United Network for Organ Sharing Analysis

    by Hosam F. Ahmed, Kevin Kulshrestha, John T. Kennedy, Amalia Gomez-Guzman, Jason W. Greenberg, Monir Hossain, Yin Zhang, David A. D’aLessandro, Ranjit John, Nader Moazami, et al.